A thorough literature survey has revealed that most of the selected drugs may or may not be official in Pharmacopoeia and a number of analytical methods are available for their individual estimation or in combination with some other drug but no analytical method is reported for the simultaneous estimation of the drugs in standard laboratory mixture or in commercial formulation available in the Indian market. Therefore some selective methods reported for the drugs selected present study are mentioned in the following section 
Simultaneous HPLC Determination of Butenafine Hydrochloride and Betamethasone in a Cream Formulation
A fast, specific, accurate and precise reverse phase high performance liquid chromatographic method was developed for the simultaneous determination of butenafine hydrochloride and betamethasone in cream formulation. The determination was carried out on licrocart licrosphere RP-select B (250×4.6 mm, 5 μ) column in isocratic mode, the mobile phase consisting of 50 mM ammonium acetate buffer and acetonitrile in the ratio of 60:40, adjusted to pH 4.5 ± 0.1 with glacial acetic acid. The flow rate was 2.0 ml/min and eluent was monitored at 254 nm. The retention times of butenafine hydrochloride and betamethasone were 4.70 min and 7.76 min, respectively, and the resolution factor was greater than 4.0. Linearity of butenafine hydrochloride and betamethasone were in the range of 100-300 μg/ml and 5-15 μg/ml, respectively. The proposed method is also found to be precise and robust for the simultaneous determination of butenafine hydrochloride and betamethasone in cream formulation.
Stability-Indicating LC Assay for Butenafine Hydrochloride in Creams Using an Experimental Design for Robustness Evaluation and Photodegradation Kinetics Study
A stability-indicating liquid chromatography method for the determination of the antifungal agent butenafine hydrochloride (BTF) in a cream was developed and validated using the Plackett-Burman experimental design for robustness evaluation. Also, the drug photodegradation kinetics was determined. The analytical column was operated with acetonitrile, methanol and a solution of triethylamine 0.3% adjusted to pH 4.0 (6:3:1) at a flow rate of 1 mL/min and detection at 283 nm. BTF extraction from the cream was done with n-butyl alcohol and methanol in ultrasonic bath. The performed degradation conditions were: acid and basic media with HCl 1M and NaOH 1M, respectively, oxidation with H 2 O 2 10%, and the exposure to UV-C light. No
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Literature Survey 38 interference in the BTF elution was verified. Linearity was assessed (r 2 = 0.9999) and ANOVA showed non-significative linearity deviation (p > 0.05). Adequate results were obtained for repeatability, intra-day precision, and accuracy. Critical factors were selected to examine the method robustness with the two-level Plackett-Burman experimental design and no significant factors were detected (p > 0.05). The BTF photodegradation kinetics was determined for the standard and for the cream, both in methanolic solution, under UV light at 254 nm. The degradation process can be described by first-order kinetics in both cases. 
Betamethasone Dipropionate

Spectrophotometric Method for Simultaneous Estimation of Escitalopram Oxalate and Clonazepam in Tablet Dosage Form
A simple, accurate and precise spectrophotometric method has been developed for simultaneous The method can be used for routine quality control of pharmaceutical formulation containing Escitalopram and Clonazepam.
Study on Pharmacokinetics of Escitalopram Oxalate Tablets in Human Body
Es-citalopram oxalate tablets were administered orally at a single dose of30mg to10healthy subjects respectively,the plasma concentration of Escitalopram oxalate was determined by HPLC method,the pharmacokinetic parameter was fitted with3p97software. 
Pharmacokinetics of Escitalopram in healthy volunteers
The The parameters after multidose of 10 mg were as follows:
Method for the estimation of Escitalopram in bulk and in dosage Forms
The present study indicates a simple, accurate and precise RP-HPLC method for the estimation 
RP-HPLC Method for Simultaneous Estimation of Levamisole, Mebendazole and Albendazole in Pharmaceutical Products
Single and reproducible RP-HPLC method has been developed for the simultaneous estimation The analytical procedure has been applied to a pharmacokinetic study of Ivermectin in healthy volunteers and to the analysis of plasma specimens from patients with disseminated strongyloidiasis.
Simultaneous Analysis of Ivermectin and Clorsulon in Injection Solutions by High Performance Liquid Chromatography with Confirmation by Liquid Chromatography
Mass Spectrometry
Ivermectin and Clorsulon are antiparasitic agents used in veterinary medicine, sometimes used in combination. The purpose of this work was to develop a method for the simultaneous analysis of The analytical procedure has been applied to a pharmacokinetic study of Ivermectin in healthy volunteers and to the analysis of plasma specimens from patients with disseminated strongyloidiasis. A simple, precise and rapid RP-HPLC method was developed for the determination of Racecadotril in a pharmaceutical formulation using Gemfibrozil as internal standard. Ratio of the peak area of analyte to internal standard was used for quantification. The chromatographic separation was carried out by using a Reverse Phase C18 column (BDSHypersil). The mobile phase consisting of a mixture of 20 mM phosphate buffer (pH 3.5) and acetonitrile in the ratio of (40:60) with detection at 230 nm at a flow rate of 1 ml/min was employed. The method was statistically validated for linearity, accuracy and precision. The elution time was 6.9 min for Racecadotril and 9.8 min for Gemfibrozil. The simplicity and accuracy of the proposed method ensures its use in routine quality control analysis of pharmaceutical formulations.
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Determination of Racecadotril and its impurities by HPLC
A HPLC method was established for the determination of Racecadotril and its impurities.METHODS A ODS column was used and the mixture of acetonitrilepotassium An accurate, reproducible and specific stability-indicating method for the high performance liquid chromatography (HPLC) assay of hydrocortisone acetate, hydrocortisone alcohol, methyl p-hydroxybenzoate and propyl p-hydroxybenzoate in a pharmaceutical suspension is described.
An investigation of several column phases was undertaken and a Zorbax SB-Phenyl column gave the best selectivity and specificity due to the π-π interactions between the analytes and stationary phase. All the components were fully resolved in less than 15 min under isocratic conditions using UV detection at 254 nm with a water-methanol mobile phase. The stability-indicating method was validated over the linearity range of 25% to 150% of the nominal concentrations of each analyte. Nominal concentrations were hydrocortisone acetate (10% w/w), hydrocortisone alcohol (0.2% w/w with respect to hydrocortisone acetate), methyl p-hydroxybenzoate (0.1% w/w) and propyl p-hydroxybenzoate (0.01% w/w) respectively.
Simultaneous determination of methylparaben, propylparaben, hydrocortisone acetate and its degradation products in a topical cream by RP-HPLC.
A novel reversed-phase high-performance liquid chromatographic method with UV A reverse-phase high-performance liquid chromatographic (HPLC) method to determine hydrocortisone acetate, hydrocortisone hemisuccinate and lidocaine is described in this paper.
The separation was made in a LichrCART C 18 column using a methanolNaH(2)PO(4)/Na(2)HPO (4) 
